Debiotech is introducing, for the first time worldwide, its new Cycler for Home Dialysis at EDTA-ERA in Paris, France.
The product, called DialEaseTM because of its extreme Ease of Use, is the result of several years of intense efforts understanding all User needs, while improving the way Dialysis therapy can be delivered at home for the benefit and safety of the patient.
"DialEaseTM is not only a significant technological improvement, making dialysis at home less intrusive, more convenient and safe, but also a new way of addressing doctors', nurses' and patients' needs to ensure an overall better treatment", says Frédéric Neftel, MD, President and CEO of DEBIOTECH SA (Lausanne, Switzerland). "Over four years we had the opportunity to interact with a number of patients, nurses and expert nephrologists in order to understand the issues and limitations of Dialysis at home. We not only developed a new automated cycler for PD, but also a new way of programming a therapy based on patient specific requirements. As a result, DialEaseTM brings a total new vision to Home Peritoneal Dialysis, which will also contribute to further developments we have in mind in Home Haemodialysis and CRRT."
The DialEaseTM product integrates a number of bright innovations, such as:
"We have worked intensively to make DialEaseTM the most reliable and least intrusive product in a Patient Life, knowing how difficult dialysis at home can be", says Didier Vecten, Project Manager at DEBIOTECH SA. "The result is one that best characterizes the passion and enthusiasm of an entire team of top scientists and engineers, who have never lost track of the Patients they are proud to serve."
The product also relies on the entirely new and powerful PD Prescription Software, "DialEaseTM Expert". This software brings new tools in the hands of the nephrologist, such as the Target Prescription and the Adaptive Prescription:
More information is available at:
DialEaseTM is currently under final stage development. It is not yet CE Marked and has not yet been submitted for 510k clearance.
Business Development Manager
Debiotech S.A., Av. de Sévelin 28, 1004 Lausanne, Switzerland.
© Copyright 1995- Debiotech S.A. All rights reserved.